RPE-Targeted Laser Therapies for Central Serous Chorioretinopathy: Sublethal Modulation Versus Selective Injury and Repair—A Narrative Review
- 1Department of Ophthalmology and Visual Science, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea
Abstract
Central serous chorioretinopathy (CSC) is increasingly understood within the pachychoroid disease spectrum, with choroidal abnormalities playing a central pathogenic role. Nevertheless, the retinal pigment epithelium (RPE) remains critical to outer blood–retinal barrier function and subretinal fluid (SRF) homeostasis, and represents a potentially modifiable therapeutic target. RPE-targeted laser therapies employ biologically distinct approaches, ranging from sublethal RPE modulation with subthreshold micropulse laser and nondamaging retinal laser therapy to selective RPE injury followed by repair with selective retina therapy. We reviewed their laser–tissue interactions, dosimetry, clinical outcomes, and safety in CSC, focusing on how different RPE responses contribute to fluid resolution. Experimental and clinical observations provide a biological basis for considering how sublethal RPE modulation and selective RPE injury followed by repair may contribute to restoration of the RPE barrier and fluid homeostasis through distinct biological responses. Nevertheless, the mechanisms linking these RPE responses to SRF resolution remain incompletely understood. RPE-targeted laser therapies represent both potential therapeutic approaches and a means of gaining mechanistic insight into the contribution of RPE dysfunction to CSC. However, despite their distinct biological rationales, the clinical evidence supporting these modalities remains heterogeneous and insufficient to establish their comparative efficacy. Optimal treatment parameters, patient selection, and the long-term efficacy and safety of repeated treatment remain to be established.
Related
- Phyllodes Tumors of the Breast in 2026: A Contemporary Narrative Review of Diagnosis, Surgical Margins, Prognosis, and Emerging Therapies
- Practical Challenges of Switching and Cross-Titration Between Incretin-Based Therapies in Type 2 Diabetes and Obesity: A Narrative Review
- Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension: A Narrative Review of Current Evidence
- An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres
- Host Modulation Through Next-Generation Oral Probiotics: Can Targeted Microbiome Modulation Reverse the Inflammatory State in Periodontitis? A Narrative Review
BibTeX
@article{jeon2026rpetargeted,
title = {{RPE-Targeted Laser Therapies for Central Serous Chorioretinopathy: Sublethal Modulation Versus Selective Injury and Repair—A Narrative Review}},
author = {Seung Hee Jeon and Jeong Ah Shin and Young-Jung Roh},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218600},
url = {https://www.mdpi.com/2077-0383/15/21/8600},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - RPE-Targeted Laser Therapies for Central Serous Chorioretinopathy: Sublethal Modulation Versus Selective Injury and Repair—A Narrative Review
AU - Seung Hee Jeon
AU - Jeong Ah Shin
AU - Young-Jung Roh
PY - 2026
DA - 2026/11/04
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218600
UR - https://www.mdpi.com/2077-0383/15/21/8600
AB - Central serous chorioretinopathy (CSC) is increasingly understood within the pachychoroid disease spectrum, with choroidal abnormalities playing a central pathogenic role. Nevertheless, the retinal pigment epithelium (RPE) remains critical to outer blood–retinal barrier function and subretinal fluid (SRF) homeostasis, and represents a potentially modifiable therapeutic target. RPE-targeted laser therapies employ biologically distinct approaches, ranging from sublethal RPE modulation with subthreshold micropulse laser and nondamaging retinal laser therapy to selective RPE injury followed by repair with selective retina therapy. We reviewed their laser–tissue interactions, dosimetry, clinical outcomes, and safety in CSC, focusing on how different RPE responses contribute to fluid resolution. Experimental and clinical observations provide a biological basis for considering how sublethal RPE modulation and selective RPE injury followed by repair may contribute to restoration of the RPE barrier and fluid homeostasis through distinct biological responses. Nevertheless, the mechanisms linking these RPE responses to SRF resolution remain incompletely understood. RPE-targeted laser therapies represent both potential therapeutic approaches and a means of gaining mechanistic insight into the contribution of RPE dysfunction to CSC. However, despite their distinct biological rationales, the clinical evidence supporting these modalities remains heterogeneous and insufficient to establish their comparative efficacy. Optimal treatment parameters, patient selection, and the long-term efficacy and safety of repeated treatment remain to be established.
SN - 2077-0383
ER -